The increased expression of pro-inflammatory and pro-angiogenic chemokines contributes to ovarian cancer progression through the induction of tumor cell proliferation, survival, angiogenesis, and metastasis. The substantial potential of these chemokines to facilitate the progression and metastasis of ovarian cancer underscores the need for their stringent transcriptional regulation. In this Review, we highlight the key mechanisms that regulate the transcription of pro-inflammatory chemokines in ovarian cancer cells, and that have important roles in controlling ovarian cancer progression. We further discuss the potential mechanisms underlying the increased chemokine expression in drug resistance, along with our perspective for future studies
Ovarian cancer is the leading cause of gynecologic cancer mortality worldwide. The aim of this revie...
Constitutive production of inflammatory cytokines is a characteristic of many human malignant cell l...
Ovarian cancer is the leading cause of gynecologic cancer mortality worldwide. The aim of this revie...
The increased expression of pro-inflammatory and pro-angiogenic chemokines contributes to ovarian ca...
Ovarian carcinoma is the deadliest gynecologic malignancy with very poor rate of survival, and it is...
Abstract: Ovarian carcinoma is the deadliest gynecologic malignancy with very poor rate of survival,...
Ovarian cancer is the most common type of gynecologic malignancy. Despite advances in surgery and ch...
Inflammation plays a role in the initiation and development of many types of cancers, including epit...
Ovarian cancer is an inflammation-associated malignancy with a high mortality rate. CXCR2 expressing...
<div><p>Ovarian cancer is an inflammation-associated malignancy with a high mortality rate. CXCR2 ex...
PublishedJournal ArticleThis is the final version of the article. Available from Cancer Research UK ...
Epithelial ovarian cancer (EOC) is a highly lethal gynecological cancer for which overall prognosis ...
Ovarian cancer is an inflammation-associated malignancy with a high mortality rate. CXCR2 expressing...
Ovarian cancer (OC) is associated with poor outcomes and challenges scientists and clinicians. It is...
Background: Cytokines, chemokines, and chemokine receptors regulate the proliferation and survival o...
Ovarian cancer is the leading cause of gynecologic cancer mortality worldwide. The aim of this revie...
Constitutive production of inflammatory cytokines is a characteristic of many human malignant cell l...
Ovarian cancer is the leading cause of gynecologic cancer mortality worldwide. The aim of this revie...
The increased expression of pro-inflammatory and pro-angiogenic chemokines contributes to ovarian ca...
Ovarian carcinoma is the deadliest gynecologic malignancy with very poor rate of survival, and it is...
Abstract: Ovarian carcinoma is the deadliest gynecologic malignancy with very poor rate of survival,...
Ovarian cancer is the most common type of gynecologic malignancy. Despite advances in surgery and ch...
Inflammation plays a role in the initiation and development of many types of cancers, including epit...
Ovarian cancer is an inflammation-associated malignancy with a high mortality rate. CXCR2 expressing...
<div><p>Ovarian cancer is an inflammation-associated malignancy with a high mortality rate. CXCR2 ex...
PublishedJournal ArticleThis is the final version of the article. Available from Cancer Research UK ...
Epithelial ovarian cancer (EOC) is a highly lethal gynecological cancer for which overall prognosis ...
Ovarian cancer is an inflammation-associated malignancy with a high mortality rate. CXCR2 expressing...
Ovarian cancer (OC) is associated with poor outcomes and challenges scientists and clinicians. It is...
Background: Cytokines, chemokines, and chemokine receptors regulate the proliferation and survival o...
Ovarian cancer is the leading cause of gynecologic cancer mortality worldwide. The aim of this revie...
Constitutive production of inflammatory cytokines is a characteristic of many human malignant cell l...
Ovarian cancer is the leading cause of gynecologic cancer mortality worldwide. The aim of this revie...